Results 41 to 50 of about 405,448 (165)
Phenoconversion and therapeutic drug monitoring [PDF]
Keywords: clobazam; clozapine; genotype–phenotype mismatch; personalized medicine; pharmacogenetics; risperidone; therapeutic drug monitoring ...
openaire +2 more sources
Hypertrophic cardiomyopathy (HCM) is a prevalent and often underdiagnosed genetic cardiac disorder characterized by left ventricular hypertrophy and, in many cases, dynamic left ventricular outflow tract obstruction (LVOTO).
Arnold Kukowka, Marek Droździk
doaj +1 more source
A possible interaction between linezolid and digoxin: A case report of therapeutic drug monitoring
Drug-drug interactions lead to altered clinical effects, including adverse reactions. Therapeutic drug monitoring of digoxin is necessary due to its narrow therapeutic range.
Zhu Yulin +3 more
doaj +1 more source
Where next for antiepileptic therapeutic drug monitoring? [PDF]
nema
Janković Slobodan M.
doaj +1 more source
Aims: Cetirizine is frequently administered at an increased dosage in clinical practice and recommended by several guidelines. Nonetheless, the pharmacokinetic (PK) profile and real-world safety data remain insufficient in the Chinese pediatric ...
Wei Liu +11 more
doaj +1 more source
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
Background Pazopanib is a tyrosine kinase inhibitor indicated for the treatment of renal cell carcinoma and soft tissue sarcoma. Despite the high inter-patient variability in pharmacokinetic exposure, pazopanib is administered at a fixed dose of 800 mg ...
Stefanie L. Groenland +3 more
doaj +1 more source
The accumulation of classic or 11-oxygenated androgens is a hallmark of polycystic ovary syndrome (PCOS). Traditional electrochemiluminescence immunoassays (ECLIA) are limited in their ability to measure a broad spectrum of androgens and may suffer from ...
Xianhua Zhang +9 more
doaj +1 more source
Effects of fluvoxamine on duloxetine plasma concentrations: A case series
Objective: Duloxetine is metabolized in liver by CYP1A2 enzyme. Concomitant Concomitant use of fluvoxamine, which is an inhibitor of CYP 1A2 enzyme with duloxetine may increase bioavailability of duloxetine from 42,8% to 81.9%, and plasma levels by 141%-
Esra Sağlam +4 more
doaj
Objectives: This study aims to examine whether the allograft inflammatory factor-1 (AIF1) gene rs2269475:C>T polymorphism is associated with rheumatoid arthritis (RA) susceptibility, and whether this polymorphism influences disease activity in patients ...
Andrzej PAWLIK +3 more
doaj
Therapeutic Drug Monitoring [PDF]
Ramona, Dolscheid-Pommerich +1 more
openaire +2 more sources

